- Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells
Jie Zhou et al, 2018, Seminars in Immunology CrossRef - Inflammatory cell indexes as preoperative predictors of hospital stay in open elective thoracic surgery
Panagiotis Paliogiannis et al, 2018, ANZ Journal of Surgery CrossRef - Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab
Carlo Putzu et al, 2018, Cancer Immunol Immunother CrossRef - Immune-checkpoint inhibitors in non-small cell lung cancer: a tool to improve patients’ selection
Giuseppe Luigi Banna et al, 2018, Critical Reviews in Oncology/Hematology CrossRef - Immunotherapy in non-small-cell lung cancer: a bridge between research and clinical practice
Passiglia Francesco et al, 2018, Future Oncology CrossRef - A reliable and feasible way to predict the benefits of Nivolumab in patients with non-small cell lung cancer: a pooled analysis of 14 retrospective studies
Dedong Cao et al, 2018, OncoImmunology CrossRef - Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas
Won Jin Ho et al, 2018, j. immunotherapy cancer CrossRef - Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy
Dong Guo et al, 2018, Future Oncology CrossRef - Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors
David Aguiar-Bujanda et al, 2018, Oncol Res Treat CrossRef - Role of preoperative blood markers as prognostic factors for lung cancer surgery
Umar Imran Hamid et al, 2019, Asian Cardiovasc Thorac Ann CrossRef - Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients
Francesco Passiglia et al, 2019, Ther Adv Med Oncol CrossRef - Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio
Cierra S. Hong et al, 2019, Advances in Orthopedics CrossRef - The prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy
Ufuk Yılmaz et al, 2018, Indian J Cancer CrossRef - The prognostic values of neutrophil to lymphocyte ratio for outcomes in chronic obstructive pulmonary disease
Zengpanpan Ye et al, 2019, Medicine CrossRef - Prognostic Significance of Hematological Indices in Malignant Melanoma Treated With Immune Checkpoint Inhibitors
Muhammad Z. Afzal et al, 2019, Journal of Immunotherapy CrossRef - Clinical Significance of SERPINA1 Gene and Its Encoded Alpha1-antitrypsin Protein in NSCLC
null Ercetin et al, 2019, Cancers CrossRef - Neutrophil‐to‐lymphocyte ratio and risk of lung cancer mortality in a low‐risk population: A cohort study
Jihoon Kang et al, 2019, Int. J. Cancer CrossRef - Frailty in Older Patients Referred to Oncology, and Impact of Treatment: Use of a Modified 6 Item Score
Bridget Robinson et al, 2019, COR CrossRef - Prognostic value of the pretreatment albumin:globulin ratio combined with adult comorbidity evaluation 27 and TMN staging in patients with squamous cell carcinoma of the maxillary sinus
B. Zhong et al, 2019, British Journal of Oral and Maxillofacial Surgery CrossRef - Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC
Julia Kargl et al, 2019 CrossRef - Circulating neutrophil subsets in advanced lung cancer patients exhibit unique immune signature and relate to prognosis
Merav E. Shaul et al, 2020, FASEB j. CrossRef - Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer
Qing Huang et al, 2020, Medicine CrossRef - The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis
Yan Lu et al, 2020, PLoS ONE CrossRef - The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies - A Narrative Review.
Paulina Stefaniuk et al, 2020, Cancer Manag Res CrossRef - The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer
Ali Yılmaz et al, 2020, Lung CrossRef - The Significance of Hematologic Indicators in the Prognosis of Patients with Advanced Lung Adenocarcinoma
镭蓉 王, 2020, ACM CrossRef - Good cops turn bad: The contribution of neutrophils to immune-checkpoint inhibitor treatment failures in cancer
Huajia Zhang et al, 2020, Pharmacology & Therapeutics CrossRef - Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers
Hui Xuan Lim et al, 2020, IJMS CrossRef - Neutrophil-to-lymphocyte ratio can predict outcome in extensive-stage small cell lung cancer
Gordana Drpa et al, 2020 CrossRef - Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Non-Small-Cell Lung Cancer
Manman Guo et al, 2020, ATCS CrossRef - Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies
Meghan A. Cupp et al, 2020, BMC Med CrossRef - Simple parameters to solve a complex issue: predicting response to checkpoint inhibitor therapy in lung cancer
James Newman et al, 2020, Lung Cancer Management CrossRef - Methylation-derived Neutrophil-to-Lymphocyte Ratio and Lung Cancer Risk in Heavy Smokers
Laurie Grieshober et al, 2018, Cancer Prev Res CrossRef - Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-mutated Non-Small Cell Lung Cancer: Single Institution Analysis, Systematic Review and Meta-Analysis
Sze Wah Samuel Chan et al, 2021, Clinical Lung Cancer CrossRef - Prognostic Factors Determining Survival of Patients Operated for Non-Small Cell Lung Cancer with Consideration Given to Morphological Parameters of Blood
Mariusz Łochowski et al, 2021, CMAR CrossRef - Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy
Cinzia Baldessari et al, 2021, Clinical Nutrition ESPEN CrossRef - Systemic inflammation, TNM staging and survival in patients with lung cancer
Ionela Erhan et al, 2020 CrossRef - Prognostic utility of inflammation-based biomarkers, neutrophil–lymphocyte ratio and change in neutrophil–lymphocyte ratio, in surgically resected lung cancers
Daniel Thompson et al, 2021, Ann Thorac Med CrossRef - Neutrophil‐to‐Lymphocyte Ratio Predicts High‐Risk Explant Features and Waitlist Survival But Is Not Independently Associated With Recurrence or Survival Following Liver Transplantation for Hepatocellular Carcinoma
Emily Harding‐Theobald et al, 2021, Liver Transpl. CrossRef - Pre-diagnosis neutrophil-to-lymphocyte ratio and mortality in individuals who develop lung cancer
Laurie Grieshober et al, 2021, Cancer Causes Control CrossRef - Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma
Daniel J. Gross et al, 2021, Journal of Thoracic Oncology CrossRef - The clinical relevance of lymphocyte to monocyte ratio in patients with Idiopathic Pulmonary Fibrosis (IPF)
Nicol Bernardinello et al, 2022, Respiratory Medicine CrossRef - Inflammation-scores as prognostic markers of overall survival in lung cancer: a register-based study of 6,210 Danish lung cancer patients
Anne Winther-Larsen et al, 2022, BMC Cancer CrossRef - Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer
Alex K. Bryant et al, 2022, Lung Cancer CrossRef - Use of neutrophil/lymphocyte ratio (NLR) and lymphocyte/monocyte ratio (LMR) as biomarkers in the differential diagnosis of malignant solitary pulmonary nodules
Murat Kuru et al, 2022, Med Sci Discov CrossRef - Pretreatment Neutrophil-to-Lymphocyte Ratio and Smoking History as Prognostic Factors in Advanced Non–Small Cell Lung Cancer Patients Treated with Osimertinib
Ji Young Park et al, 2022, Tuberc Respir Dis CrossRef - Immune Modulation in Lung Cancer: Current Concepts and Future Strategies
Lena Gaissmaier et al, 2020, Respiration CrossRef - Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
Liangliang Xu et al, 2022, J Hematol Oncol CrossRef - Prognostic predictors of non-small cell lung cancer treated with curative resection: the role of preoperative CT texture features, clinical features, and laboratory parameters
L. Zhou et al, 2022, Clinical Radiology CrossRef - Role of Polyamines as Biomarkers in Lymphoma Patients: A Pilot Study
Donatella Coradduzza et al, 2022, Diagnostics CrossRef - Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy?
Smith David et al, 2023, Seminars in Oncology CrossRef - Predictive value of neutrophil-to-lymphocyte, lymphocyte-to-monocyte, and platelet-to-lymphocyte ratios in adult and pediatric acute lymphoblastic leukemia patients
MariamK Youssef et al, 2022, Egypt J Haematol CrossRef - Using preoperative control nutritional status scores as prognostic factors for endometrial cancer
Jing Yuan et al, 2023, Front. Oncol. CrossRef - Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in non-small cell lung cancer
Mesut Bayraktaroglu et al, 2023 CrossRef - Association of A1AT genetic polymorphism and NSCLC: a case- control study in Egyptian population
Aliaa N. El-Dawa et al, 2023, BMC Med Genomics CrossRef - The impact of comorbidities, neutrophil-to-lymphocyte ratio, and drug toxicities on quality of life in lung cancer patients receiving EGFR-TKI therapy
Jung-Yueh Chen et al, 2023, Journal of the Formosan Medical Association CrossRef - Tumor-associated neutrophils upregulate PANoptosis to foster an immunosuppressive microenvironment of non-small cell lung cancer
Qin Hu et al, 2023, Cancer Immunol Immunother CrossRef - Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients
Francesca Pettinella et al, 2023, Cancers CrossRef - The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study
Hironobu Samejima et al, 2023, BMC Cancer CrossRef - Increased expression of individual genes in whole blood is associated with late-stage lung cancer at and close to diagnosis
Ilona Urbarova et al, 2023, Sci Rep CrossRef - Association between Physical Activity and Reduced Mortality in Inoperable Lung Cancer
Vinicius Cavalheri et al, 2023, JCM CrossRef - Role of Blood Cell Indexes in Progresses to ESRD
Duong Thi Ngoc Lan et al, 2024, Ind J Clin Biochem CrossRef - Pretreament neutrophil-lymphocyte ratio (NLR): A felicitous prognostic marker in carcinoma lung
Shailley A. Sehgal et al, 2023 CrossRef - Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes
Esmeralda Garcia-Torralba et al, 2024, Breast Cancer Res Treat CrossRef - Prognostic importance of prognostic nutritional index and modified Glasgow prognostic score in advanced lung cancer with targetable mutation
Burak Bilgin et al, 2024, J Cancer Res Clin Oncol CrossRef - Pre-Operative Measures of Systemic Inflammation Predict Survival After Surgery for Primary Lung Cancer
Marcus Taylor et al, 2024, Clinical Lung Cancer CrossRef - The Multifaceted Role of Neutrophils in NSCLC in the Era of Immune Checkpoint Inhibitors
Shucheng Miao et al, 2024, Cancers CrossRef - A Preliminary Study on the Prognostic Impact of Neutrophil to Lymphocyte Ratio of the Bronchoalveolar Lavage Fluid in Patients with Lung Cancer.
Woo Kyung Ryu et al, 2021, Diagnostics (Basel) CrossRef - Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysis
Qiaofeng Zhong et al, 2024, Ther Adv Med Oncol CrossRef - Clinical significance of postoperative thrombocytosis after vats lobectomy for NSCLC
Beatrice Leonardi et al, 2024, J Cardiothorac Surg CrossRef - Food Aversion, Systemic Inflammation and Intramuscular Adipose Tissue are Mortality Predictors in Advanced Lung Cancer Patients
Willian das Neves et al, 2024, JCSM Communications CrossRef - Associations between peripheral whole blood cell counts derived indexes and cancer prognosis: An umbrella review of meta-analyses of cohort studies
Ying-Ying Zhang et al, 2024, Critical Reviews in Oncology/Hematology CrossRef - Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005)
Esra Gumustepe et al, 2024 CrossRef - Clinical Significance of the Peripheral Blood Neutrophil-to-Lymphocyte Ratio in Predicting Chemotherapy Outcomes for Small Cell Lung Cancer
Li Gao et al, 2025, CMAR CrossRef